Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Autor: Chalmers JR; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Thomas KS; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Apfelbacher C; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Williams HC; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Prinsen CA; Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands., Spuls PI; Department of Dermatology, Academic Medical Center, Amsterdam, the Netherlands., Simpson E; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Gerbens LAA; Department of Dermatology, Academic Medical Center, Amsterdam, the Netherlands., Boers M; VU University Medical Center, Amsterdam, the Netherlands., Barbarot S; Department of Dermatology, Nantes University Hospital (CHU de Nantes), France., Stalder JF; Department of Dermatology, Nantes University Hospital (CHU de Nantes), France., Abuabara K; Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A., Aoki V; University of São Paulo Medical School, São Paulo, Brazil., Ardeleanu M; Regeneron Pharmaceuticals, Tarrytown, NY, U.S.A., Armstrong J; Galderma, Paris, France., Bang B; LEO Pharma, Ballerup, Denmark., Berents TL; Oslo University Hospital, Oslo, Norway., Burton T; Patient, Nottingham, U.K., Butler L; National Eczema Association, San Rafael, CA, U.S.A., Chubachi T; GlaxoSmithKline, Research Triangle Park, NC, U.S.A., Cresswell-Melville A; Eczema Society of Canada, Keswick, ON, Canada., DeLozier A; Eli Lilly and Company, Indianapolis, IN, U.S.A., Eckert L; Sanofi, Chilly-Mazarin, France., Eichenfield L; Rady Children's Hospital, University of California San Francisco, San Diego, CA, U.S.A., Flohr C; St John's Institute of Dermatology, St Thomas' Hospital, London, U.K., Futamura M; Nagoya Medical Center, Nagoya, Japan., Gadkari A; Regeneron Pharmaceuticals, Tarrytown, NY, U.S.A., Gjerde ES; The Psoriasis and Eczema Association of Norway, Oslo, Norway., van Halewijn KF; Erasmus MC, University Medical Centre, Rotterdam, the Netherlands., Hawkes C; GlaxoSmithKline, Uxbridge, U.K., Howells L; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Howie L; Global Parents for Eczema Research, Brisbane, Australia., Humphreys R; National Eczema Society, London, U.K., Ishii HA; Brazilian Atopic Dermatitis Association (AADA), São Paulo, Brazil., Kataoka Y; Osaka Prefectural Medical Center for Respiratory and Allergic Disease, Osaka, Japan., Katayama I; Osaka University, Osaka, Japan., Kouwenhoven W; Dutch Association for People with Atopic Dermatitis, Nijkerk, the Netherlands., Langan SM; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, U.K., Leshem YA; Beilinson Hospital and Tel Aviv University, Petah Tikva and Tel Aviv, Israel., Merhand S; Association Française de l'Eczéma, Redon, France., Mina-Osorio P; Regeneron Pharmaceuticals, Tarrytown, NY, U.S.A., Murota H; Department of Dermatology, Osaka University, Suita, Japan., Nakahara T; Department of Dermatology, Kyushu University, Fukuoka, Japan., Nunes FP; Eli Lilly and Company, Indianapolis, IN, U.S.A., Nygaard U; Eli Lilly and Company, Indianapolis, IN, U.S.A., Nygårdas M; Sanofi Genzyme, Stockholm, Sweden., Ohya Y; National Centre for Child Health and Development, Tokyo, Japan., Ono E; Osaka University, Osaka, Japan., Rehbinder E; Department of Dermatology, Oslo University Hospital, Oslo, Norway., Rogers NK; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Romeijn GLE; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Schuttelaar MLA; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Sears AV; St John's Institute of Dermatology, St Thomas' Hospital, London, U.K., Simpson MA; Dermavant Sciences, Inc., Durham, NC, U.S.A., Singh JA; Department of Medicine, University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, AL, U.S.A., Srour J; Klinik und Poliklinik für Dermatologie und Allergologie der LMU - München, Munich, Germany., Stuart B; Primary Care and Population Sciences Division, University of Southampton, Southampton, U.K., Svensson Å; Department of Dermatology and Venereology, Lund University, Malmö, Sweden., Talmo G; The Psoriasis and Eczema Association of Norway, Haugesund, Norway., Talmo H; The Psoriasis and Eczema Association of Norway, Haugesund, Norway., Teixeira HD; AbbVie Inc., North Chicago, IL, U.S.A., Thyssen JP; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark., Todd G; University of Cape Town, Cape Town, South Africa., Torchet F; Association Française de l'Eczéma, Redon, France., Volke A; Department of Dermatology, University of Tartu, Tartu, Estonia., von Kobyletzki L; Department of Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.; Department of Public Health Sciences, Karlstad University, Karlstad, Sweden.; CF Wahlgren, Dermatology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; Department of Dermatology, Venereology and Allergy University Hospital Schleswig-Holstein, Kiel, Germany., Weisshaar E; Department of Social Medicine, Occupational and Environmental Dermatology, Ruprecht Karls University, Heidelberg, Germany., Wollenberg A; Ludwig-Maximilian University, Munich, Germany., Zaniboni M; University of São Paulo, Campinas, Brazil.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2018 May; Vol. 178 (5), pp. e332-e341. Date of Electronic Publication: 2018 Apr 19.